Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study

Authors:

Abstract
No abstract available
Funding Information
  • Amgen (Not applicable)
  • Amgen (Not applicable)

This publication has 8 references indexed in Scilit: